DASATINIB S.K. 20 MG

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

DASATINIB

Tersedia dari:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

Kode ATC:

L01XE06

Bentuk farmasi:

FILM COATED TABLETS

Komposisi:

DASATINIB 20 MG

Rute administrasi :

PER OS

Jenis Resep:

Required

Diproduksi oleh:

REMEDICA LTD., CYPRUS

Area terapi:

DASATINIB

Indikasi Terapi:

Dasatinib is indicated for the treatment of adult patients with:• newly diagnosed Philadelphia-chromosome-positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase;• chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate;• Ph+ acute lymphoblastic leukaemia (ALL) and lymphoid blast CML with resistance or intolerance to prior therapy.

Tanggal Otorisasi:

2023-09-20